These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5475414)

  • 1. [Electroencephalographic effects of fluphonazine decanoate].
    Borenstein P; Cujo P; Dumaine A
    Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414
    [No Abstract]   [Full Text] [Related]  

  • 2. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
    Borenstein P; Dumaine A; Cujo P
    Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI; Barron A; Kiriakos R
    J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
    Karkalas Y
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with fluphenazine decanoate in psychoses].
    Náhunek K; Rodová A; Svestka J
    Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical evaluation of an injectable phenothiazine in the management of acute psychotic patients.
    Verster JP
    S Afr Med J; 1967 Jan; 41(4):83-4. PubMed ID: 5335781
    [No Abstract]   [Full Text] [Related]  

  • 13. New concept in phenothiazine therapy: fluphenazine enanthate and fluphenazine decanoate.
    Sanseigne AJ; Yale HL; Hess SM; Burke JC; Horovitz ZP
    Agressologie; 1968; 9(2):309-13. PubMed ID: 5675497
    [No Abstract]   [Full Text] [Related]  

  • 14. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between electroencephalographic deviations following anti-psychotic drug treatment and the course of mental illness.
    Dasberg H; Robinson S
    Isr Ann Psychiatr Relat Discip; 1969 Nov; 7(2):185-200. PubMed ID: 5274357
    [No Abstract]   [Full Text] [Related]  

  • 16. [New method of chemotherapy in psychiatry with a neuroleptic with prolonged effect: fluphenazine enanthate].
    Gayral L; Oules J; Fourny L; Grandmontagne O; Millet L; Peretti A; Roux G; Durou B
    Sem Hop; 1968 Apr; 44(19):1298-300. PubMed ID: 4298956
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis.
    Keskiner A; Itil T; Han H; Hsu W; Ulett G
    Psychopharmacologia; 1971; 20(3):230-41. PubMed ID: 5565254
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of long-acting injectable Prolixin in 23 psychotic patients.
    Whittier JR; Korenyi C; Haydu GG; Goldschmidt L
    Dis Nerv Syst; 1967 Jul; 28(7 Pt 1):459-61. PubMed ID: 4951982
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between the behavioral and electroencephalographic effects of chlorpromazine and fluphenazine in rats.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1975; 13(6):520-5. PubMed ID: 1221434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.